Literature DB >> 7358496

Acute effect of epinephrine on aqueous humor formation in the timolol-treated normal eye as measured by fluorophotometry.

R G Higgins, R F Brubaker.   

Abstract

A double-blind, randomized, placebo-control study of the effect of epinephrine on the rate of aqueous formation in eyes pretreated with a beta-adenergic blocking drug was carried out in 25 normal subjects with the use of fluorophotometry. All eyes were pretreated with timolol maleate before epinephrine or placebo was given. The effect of timolol maleate alone was to lower intraocular pressure and to reduce the rate of formation of aqueous humor. In the presence of timolol, aqueous formation was decreased further, approximately 7% more, in the epinephrine treated-eye as compared to the placebo-treated eye. This additional decrease in aqueous formation was statistically significant. No statistically significant difference was found in intraocular pressure or in tonographic C value between the epinephrine-treated and the placebo-treated eye. However, intraocular pressure was so low in both eyes that differences in intraocular pressure were not expected and tonographic tracings were difficult to interpret.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7358496

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  3 in total

1.  The efficacy of the combination of l-moprolol and dipivefrin in reducing the intraocular pressure in primary open-angle glaucoma or in ocular hypertension.

Authors:  L Rossetti; P Barbieri; P Velati; E Bujtar; N Orzalesi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-11       Impact factor: 3.117

Review 2.  The flow of aqueous humor in the human eye.

Authors:  R F Brubaker
Journal:  Trans Am Ophthalmol Soc       Date:  1982

3.  Dose response of oral timolol combined with adrenaline.

Authors:  A Ohrström
Journal:  Br J Ophthalmol       Date:  1982-04       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.